Granules India Ltd

Granules India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Granules India Ltd

₹ 592 -1.27%
20 Dec - close price
granulesindia.com BSE: 532482 NSE: GRANULES
About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 14,365 Cr.
  • Current Price ₹ 592
  • High / Low ₹ 725 / 382
  • Stock P/E 29.5
  • Book Value ₹ 141
  • Dividend Yield 0.25 %
  • ROCE 15.4 %
  • ROE 13.4 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Dividend payout has been low at 8.34% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.17%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of BSE 250 SmallCap Index BSE 400 MidSmallCap Index BSE SmallCap Nifty Pharma BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
888 997 1,030 1,020 1,151 1,146 1,196 986 1,189 1,156 1,176 1,180 967
737 823 837 808 908 915 967 849 977 905 920 921 763
Operating Profit 151 174 193 212 243 231 228 137 213 250 256 259 203
OPM % 17% 17% 19% 21% 21% 20% 19% 14% 18% 22% 22% 22% 21%
4 5 4 5 5 1 3 0 2 1 2 2 3
Interest 5 5 6 7 13 17 19 22 26 29 29 27 26
Depreciation 40 39 40 43 44 48 49 49 53 52 53 53 53
Profit before tax 110 135 150 166 190 167 164 65 136 170 176 181 128
Tax % 27% 25% 26% 23% 24% 26% 27% 27% 25% 26% 26% 26% 24%
81 101 111 128 145 124 120 48 102 126 130 135 97
EPS in Rs 3.26 4.07 4.48 5.14 5.84 5.14 4.94 1.98 4.21 5.18 5.35 5.56 4.01
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
761 1,084 1,292 1,357 1,411 1,685 2,279 2,599 3,238 3,765 4,512 4,506 4,478
676 925 1,082 1,081 1,112 1,406 1,895 2,073 2,382 3,038 3,597 3,648 3,509
Operating Profit 86 159 210 276 299 278 384 526 856 727 915 858 969
OPM % 11% 15% 16% 20% 21% 17% 17% 20% 26% 19% 20% 19% 22%
1 4 3 5 35 27 75 90 26 13 12 2 8
Interest 18 20 32 37 32 33 28 27 26 23 56 106 110
Depreciation 23 30 53 58 72 76 105 137 151 159 184 207 211
Profit before tax 46 112 128 186 230 196 326 451 704 558 687 547 656
Tax % 30% 33% 29% 33% 28% 32% 27% 26% 22% 26% 25% 26%
33 75 91 123 165 133 236 335 549 413 517 405 487
EPS in Rs 1.62 3.71 4.45 5.68 7.19 5.22 9.30 13.19 22.18 16.64 21.34 16.72 20.10
Dividend Payout % 12% 9% 11% 11% 13% 19% 11% 8% 7% 9% 7% 9%
Compounded Sales Growth
10 Years: 15%
5 Years: 15%
3 Years: 12%
TTM: -1%
Compounded Profit Growth
10 Years: 18%
5 Years: 11%
3 Years: -10%
TTM: 24%
Stock Price CAGR
10 Years: 22%
5 Years: 36%
3 Years: 21%
1 Year: 54%
Return on Equity
10 Years: 18%
5 Years: 19%
3 Years: 17%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 20 20 20 22 23 25 25 25 25 25 24 24 24
Reserves 255 336 411 640 881 1,279 1,504 1,818 2,149 2,562 2,811 3,201 3,403
270 442 482 641 656 978 991 892 849 1,106 1,136 1,315 1,097
137 194 289 260 319 388 458 487 690 819 932 957 908
Total Liabilities 683 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903 5,498 5,433
263 482 617 560 644 777 944 1,204 1,332 1,541 1,911 2,096 2,126
CWIP 109 125 62 77 267 515 496 294 239 356 239 272 411
Investments 10 0 0 70 108 157 210 19 19 20 21 22 22
301 385 524 856 859 1,222 1,328 1,706 2,123 2,594 2,732 3,109 2,874
Total Assets 683 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,903 5,498 5,433

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
91 108 150 151 188 -1 262 476 432 332 739 439
-128 -255 -146 -162 -326 -462 -270 -160 -277 -379 -192 -358
46 147 19 86 56 529 -17 -213 -299 190 -440 8
Net Cash Flow 10 0 24 75 -82 66 -25 103 -144 143 107 90

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 34 37 39 101 108 136 108 93 86 90 77 80
Inventory Days 107 99 110 128 145 114 112 125 205 190 182 235
Days Payable 72 77 92 91 116 112 94 102 142 124 124 135
Cash Conversion Cycle 69 59 57 138 137 138 126 116 150 156 135 179
Working Capital Days 56 48 41 115 120 156 120 116 109 119 102 121
ROCE % 13% 20% 19% 20% 18% 12% 15% 17% 25% 17% 19% 15%

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
41.98% 41.98% 41.98% 41.93% 42.02% 42.02% 42.02% 41.97% 41.97% 41.96% 38.87% 38.87%
21.38% 23.19% 23.13% 22.35% 23.66% 23.90% 21.35% 21.48% 18.78% 19.57% 20.39% 19.49%
4.34% 3.98% 3.03% 4.32% 4.75% 5.03% 6.68% 7.06% 10.16% 10.70% 14.11% 14.85%
32.30% 30.85% 31.85% 31.40% 29.56% 29.05% 29.95% 29.51% 29.10% 27.77% 26.61% 26.80%
No. of Shareholders 2,16,3852,10,7852,14,5392,16,0551,90,8941,87,7772,01,0542,07,0551,90,6911,82,1421,79,8702,02,198

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls